A case of rivaroxaban associated spontaneous hemothorax.
| Autor: | Yıldız İ; Department of Cardiology, Osmaniye State Hospital, Osmaniye, Turkey., Aksu E; Department of Thoracic Surgery, Osmaniye State Hospital, Osmaniye, Turkey., Özmen Yıldız PÖ; Department of Cardiology, Osmaniye State Hospital, Osmaniye, Turkey., Gürbak İ; Department of Cardiology, Osmaniye State Hospital, Osmaniye, Turkey. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Turk gogus kalp damar cerrahisi dergisi [Turk Gogus Kalp Damar Cerrahisi Derg] 2019 Jan 01; Vol. 27 (1), pp. 118-120. Date of Electronic Publication: 2019 Jan 01 (Print Publication: 2019). |
| DOI: | 10.5606/tgkdc.dergisi.2019.15090 |
| Abstrakt: | New oral anticoagulants have emerged as an alternative for warfarin for thromboembolic prevention in patients with nonvalvular atrial fibrillation. Although new oral anticoagulants have better compliance and safety margin compared to warfarin, we must be cautious with their usage. In this article, we report a case of spontaneous hemothorax related to rivaroxaban treatment. According to our research, this is the first case of spontaneous hemothorax secondary to rivaroxaban treatment. Competing Interests: Conflict of Interest: The authors declared no conflicts of interest with respect to the authorship and/or publication of this article. (Copyright © 2019, Turkish League Against Rheumatism.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|